##
##
#
##
|Trustees||Mr G A Longhurst|||
|---|---|---|---|---|
|||DrJ M TPierce|||
|||DrJ R Wilkinson|||
|||Mr N J Lapage|||
|||Mr C H Thomson|Resigned|20/1/22|
|||Mr G Oliver|||
|||Mr N SG Scarfe|||
|||Dr T Bharucha|||
|||Mr Bill Blain|||
|||Ms P lannotti|||
|||Mr JP Evangelista|||
|||Mr P M Haydock|||
|||Mr C Morris|Appointed|20/1/22|
|Also known as||Wessex Heartbeat|||
|Chief executive officer||MrJT Munro|||
|Charity number||1116510|||
|Company|number|05924982|||
|Registered|office|Heartbeat
House|||
|||152-154Tremona Road|||
|||Southampton|||
|||Hampshire|||
|||SO166HW|||
|Auditors||Westlake Clark Audit LLP|||
|||Unit 1,West Links|||
|||Tollgate Business Park|||
|||Chandlers
Ford|||
|||Hampshire|||
|||SO53 3TG|||
|Bankers||NatWest Bank Pic|||
|||1 Rornsey Road|||
|||Shirley|||
|||Southampton|||
|||Hampshire|||
|||SO164GT|||
|Investment|advisers|Investec Wealth &Investment|||
|||Midland
House|||
|||2 Poole Road|||
|||Bournemouth|||
|||BH2 5QY|||
|Solicitors||Stillwells Solicitors|||
|||6 Carlton Crescent|||
|||Southampton|||
|||Hampshire|||
|||SO152EY|||
|||||Page|
|---|---|---|---|---|
|Trustees'
report including||directors'|report|1-6|
|Independent
auditors'|report|||7-9|
|Statement offinancial|activities|||10|
|Balance sheet|||||
|Statement ofcash flows||||12|
|Notes to the accounts||||13-22|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||Unrestricted|Restricted|Endowment|Total|Total|
|---|---|---|---|---|---|---|---|---|---|
||||||funds|funds|funds|2022|2021|
|||||Note||||||
|Income and endowments||from:||||||||
|Donations
and legacies|||||152,712|30,902||183,614|233,314|
|Other trading activities|||||196,017|6,824||202,841|145,424|
|Charitable
activities|||||3,446|||3,446|1,175|
|Investments|||||14,113|||14,113|11,017|
|Other|||||7,000|||7,000|97,471|
|Total income|||||373,288|37,726||411,014|488,401|
|Expenditure
on:||||||||||
|Raising funds||||||||||
|Costs ofgenerating|donation||income||141,575|||141,575|138,510|
|Fundraising
trading|costs||||145,694|||145,694|113,461|
|Charitable
activities|||||137,125|4,337|543|142,005|261,476|
|Total expenditure|||||424,394|4,337|543|429,274|513,447|
|Net (losses)l gains|on investments|||13|(75,310)|||(75,310)|50,009|
|Net (expenditure)I|income||||(126,416)|33,389|(543)|(93,570)|24,963|
|Transfers|||||14,164|(14,164)||||
|Net movement
in funds for|||the year||(112,252)|19,225|(543)|(93,570)|24,963|
|Reconciliation
offunds||||||||||
|Total funds brought|forward||||2,721,207|7,411|543|2,729,161|2,704,198|
|Total funds carried forward|||||2,608,955|26,636||2,635,591|2,729,161|
##
##
||||2022|2021|
|---|---|---|---|---|
|||Note|||
|Fixed assets|||||
|Tangible assets||12|1,267,464|1,218,571|
|investments||13|770,842|538,484|
||||2,038,306|1,757,055|
|Current assets|||||
|Stock||14|2,088|1,842|
|Debtors||15|45,440|36,765|
|Cash at bank and in hand|||659,300|1,064,850|
||||706,828|1,103,457|
|Creditors falling due within one year||16|(109,543)|(131,351)|
|Net curent|assets||597,285|972,106|
|Net assets|||2,635,591|2,729,161|
|The funds|ofthe charity:||||
|Endowment|funds|19||543|
|Restricted|funds|20|26,636|7,411|
|Unrestricted|funds|20|2,608,955|2,72'I,207|
|Total charity funds|||2,635,591|2,729,161|
##
##
|||2022|2021|
|---|---|---|---|
|||R||
|Cash flow from operating|activities|(38,539)|75,974|
|Cash flow from investing|activities|||
|Dividend
income and interest from investments||14,113|11,017|
|Purchase oftangible fixed|assets|(73,456)|(1,386)|
|Purchase ofinvestments||(415,751)|(33,662)|
|Proceeds from sale ofinvestments||108,083|49,614|
|Net cash flow from investing
activities||(367,011)|25,583|
|Net (decrease)/ increase|in cash|(405,550)|101,557|
|Cash at the beginning
ofthe year||1,064,850|963,293|
|Total cash atthe end of|the year|659,300|1,064,850|
##
|Reconciliation
ofnet (expendit|ure)/
income to net cash flow fr|om operating
activities||
|---|---|---|---|
|||2022|2021|
|Net (expenditure)/
income for the year||(93,570)|24,963|
|Depreciation
charges||24,563|13,282|
|Dividends
and interest from investments||(14,113)|(11,017)|
|Loss from disposal offixed assets||||
|Losses/ (gains) on investments||75,310|(50,009)|
|(Increase)/ decrease
in stock||(246)|(129)|
|(Increase)/ decrease
in debtors||(8,675)|4,903|
|(Decrease)/ increase
in creditors||(21,808)|93,982|
|Net cash flow from operating|activities|38,539|75,974|
##
##
##
##
##
|2|Summary|analysis|for donated|income||||||
|---|---|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|Endowment|Total|Total|
||||||funds|funds|Funds|2022|2021|
||||||R|||||
||Donations|and legacies||||||||
||Donations|and gifts|||95,457|30,902||126,359|121,052|
||Legacies||||57,255|||57,255|112,262|
||||||152,712|30,902||183,614|233,314|
||Costs ofgenerating||donation|income||||||
||Donation|costs|||109,551|||109,551|113,593|
||Support costs (see note 9)||||32,024|||32,024|24,917|
||||||141,575|||141,575|138,510|
||Net donations||||11,137|30,902||42,039|94,804|
||Summary|analysis|for other trading activities|||||||
||||||Merchandise|Fundraising|Trading|Total|Total|
||||||sales|events
F|income|2022
R|2021f|
||Income from other||trading activities||401|197,207|5,233|202,841|145,424|
||Fundraising
trading costs|||||||||
||Cost ofgoods||||311||2,323|2,634|2,327|
||Staging events|||||125,269||125,269|97,292|
||Support costs (see note 9)|||||17,791||17,791|13,842|
||||||311|143,060|2,323|145,694|113,461|
||Net other|trading activities|||90|54,147|2,910|57,147|31,963|
##
|Income|from c|haritable
activities|||
|---|---|---|---|---|
||||2022|2021|
||||R|F|
|Patient|support|services|3,446|1,175|
##
##
|Investment
inco|me|||||||
|---|---|---|---|---|---|---|---|
|||||||2022|2021|
|||||||F||
|Bank interest receivable||||||450|53|
|Interest from fixed interest securities||||||2,351|2,384|
|Dividend
income||||||11,312|8,580|
|||||||14,113|11,017|
|Other income||||||||
|||||||2022|2021|
||||||||F|
|Grant income regarding|||Covid|19||7,000|71,871|
|Business interruption||insurance||claim regarding|Covid 19||25,000|
|Re-imbursement|with|regard to||the fraud shown|in the 2015accounts||600|
|||||||7,000|97,471|
##
##
|Expenditure|on charitable
activities||||||
|---|---|---|---|---|---|---|
|||Education|Prevention|Treatment|Total|Total|
|||and training||and patient|2022|2021|
|||||support|||
|Direct costs|(see note 8)|||60,559|60,559|55,605|
|Grants to individuals||543||948|1,491|1,793|
|Grants to institutions||2,655|1,549|28,812|33,016|161,748|
|Governance|costs (see note 9)|2,559|5,118|17,914|25,591|25,719|
|Support costs (see note 9)||7,116|7,116|7,116|21,348|16,611|
|||12,873|13,783|115,349|142,005|261,476|
##
|Analysis|ofdirect costs on|charitable
activities||||
|---|---|---|---|---|---|
||||Patient|Total|Total|
||||support|2022|2021|
||||F|||
|Heartbeat|House running costs||25,124|25,124|17,122|
|Heartbeat|House employment|costs|30,201|30,201|33,044|
|Heartbeat|House depreciation||5,234|5,234|5,234|
|Your Healthy
Heart checks|||||205|
||||60,559|60,559|55,605|
##
|||General|Governance|Total|Total|
|---|---|---|---|---|---|
|||support|function|2022|2021|
|||||R|F|
|Salaries and|related costs|19,243|21,910|41,153|41,367|
|ITand equipment||13,031||13,031|12,240|
|Insurance||2,186||2,186|2,108|
|Training
and|staff development|948||948|0|
|General office costs||8,05&||8,051|6,684|
|Depreciation|and disposal ofassets|19,329||19,329|8,047|
|Bank charges||2,545||2,545|2,481|
|Legal and professional fees|||681|681|0|
|Audit fees||26|3,000|3,026|3,026|
|Consultancy|fees|5,790||5,790|4,962|
|Trustee meeting costs||14||14|50|
|||71,163|25,591|96,754|80,965|
##
|Net incomel (expenditu|re)
for the year||||
|---|---|---|---|---|
||||2022|2021|
|This is stated after charging:||||E|
|Operating
leases - equipment|||673|676|
|Depreciation|||24,563|13,281|
|Loss on disposal offixed assets|||||
|Auditor's
remuneration|||3,000|3,000|
|Accountancy fees|||26|26|
|Legal and professional|fees||681|0|
|Analysis ofstaff costs|and trustee remuneration|and expenses|||
||||2022|2021|
|Salaries and wages|||207,699|215,478|
|Social security costs|||14,642|15,343|
|Pension costs|||2,385|2,621|
||||224,726|233,442|
##
##
##
##
|Tangible fixed assets|||||||
|---|---|---|---|---|---|---|
||||Land and|Computer|Furniture|Total|
||||buildings|equipment|and fittings|2022|
||||||R||
|Cost|||||||
|At 1 October 2021|||1,522,608|20,593|80,178|1,623,379|
|Additions||||3,462|69,994|73,456|
|Disposals||||(3,344)|(1,642)|(4,986)|
|At 30September 2022|||1,522,608|20,711|148,530|1,691,850|
|Depreciation|||||||
|At 1 October 2021|||317,839|17,616|69,353|404,808|
|Charge for the year|||7,363|2,247|14,953|24,563|
|Eliminated
on disposals||||(3,344)|(1,642)|(4,986)|
|At 30September 2022|||325,202|16,519|82,664|424,386|
|Net BookValue|||||||
|At 30September 2022|||1,197,406|4,192|65,866|1,267,464|
|At 30September 2021|||1,204,769|2,977|10,825|1,218,571|
|Fixed asset investments|||||||
|||||Listed|Other|Total|
|||||investments|investments|2022|
|Market value|||||||
|At 1 October 2021||||538,482||538,484|
|Additions||||415,751||415,751|
|Disposals||||(108,083)||(108,083)|
|Revaluations||||(75,310)||(75,310)|
|At 30September 2022||||770,840||770,842|
|Investments
atfair value||comprise:|||2022|2021f|
|UK Fixed Interest|||||73,956|71,897|
|Overseas Fixed Interest|||||173,873|65,368|
|UK Equities|||||90,609|60,519|
|European
Equities|||||14,735|16,170|
|North American
Equities|||||73,695|44,903|
|Far East 8 Austalasian|Equities||||15,486|16,363|
|International
Equities|||||72,184|75,993|
|UK Property|||||56,344|58,214|
|Emerging
Economies|||||W|14,676|
|Alternative
Assets|||||148,722|91,538|
|Cash held for investment||purposes|||51,236|22,841|
||||||770,840|538,482|
##
|14|Stock||||
|---|---|---|---|---|
||||2022|2021|
||||R||
||Merchandise||2,088|1,842|
|15|Debtors||||
||||2022|2021|
||||R||
||Trade debtors||3,380|2,030|
||Prepayments|and accrued income|42,060|34,735|
||||45,440|36,765|
|16|Creditors||||
||||2022|2021|
||||R||
||Trade creditors||19,682|7,554|
||Tax and social security||5,692|4,773|
||Other creditors and accruals||76,465|108,361|
||Deferred income||7,704|10,663|
||||109,543|131,351|
|17|Deferred income||||
||Deferred income comprises ofadvance ticket sales ofevents occurring after the year end.||||
|||||2022f|
|---|---|---|---|---|
|Balance|as at 1 October 2021|||10,663|
|Amount|released to income earned|from charitable|activities|(10,663)|
|Amount|deferred
in year|||7,704|
|Balance|as at 30September 2022|||7,704|
##
##
|18|Analysis ofnet assets between funds||||||
|---|---|---|---|---|---|---|
|||Unrestricted|Restricted|Endowment||Total|
|||funds
R|funds|funds
f||2022
R|
||Fund balances at 30September 2022 are represented|by:|||||
||Tangible fixed assets|1,267,464||||1,267,464|
||Investments|770,842||||770,842|
||Current assets|680,192|26,636|||706,828|
||Creditors|(109,543)||||(109,543)|
|||2,608,954|26,636||0|2,635,591|
|Analysis ofnet assets between funds - previous y|ear||||
|---|---|---|---|---|
||Unrestricted|Restricted|Endowment|Total|
||funds|funds|funds|2021f|
|Fund balances at 30September 2021 are represented|by:||||
|Tangible fixed assets|1,218,571|||1,218,571|
|Investments|538,484|||538,484|
|Current assets|1,095,503|7,411|543|1,103,457|
|Creditors|(131,351)|||(131,351)|
||2,721,207|7,411|543|2,729,161|
##
##
|Endowment|funds|||||||
|---|---|---|---|---|---|---|---|
||||Balance|Incoming|Resources|Transfers|Balance|
||||1.10.21|resources|expended||30.9.22
f|
|The Heartbeat|Education|fund|543||~543|||
|Endowment|funds - previous year|||||||
||||Balance|Incoming|Resources|Transfers|Balance|
||||1.10.20|resources|expended||30.9,21|
||||||||R|
|The Heartbeat|Education|fund|64,676||~64.133||543|
##
|Analysis o|fc|haritab|le
funds||||||
|---|---|---|---|---|---|---|---|---|
|||||Balance|Incoming|Resources|Gains/losses|Balance|
|||||1.10.21|resources|expended|Transfers|30.9.22|
|Unrestricted||funds|||||||
|General fund||||2,721,207|373,288|~424,394|~61,146|2,608,955|
|Restricted|funds||||||||
|MRI fund||||42||||42|
|Heartbeat|House fund|||5,300|23,100|(3,087)||25,313|
|Heart Failure||Unit fund||46||||46|
|3D Printer|appeal||||14,164||(14,164)||
|Healthy
Living||Centre appeal||50|187|||237|
|Paediatric|Palliative||Clinical Nurse appeal|1,973|255|||2,228|
|Prehab
pilot||||||(1,250)||(1,250)|
|Explain my|procedure||||20|||20|
|||||7,411|37,726|~4,337|~14,164|26,636|
##
|Analysis|ofc|haritab|le
funds - previous
y|ear|||||
|---|---|---|---|---|---|---|---|---|
|||||Balance|Incoming|Resources|Gains/ losses|Balance|
|||||1.10.20|resources|expended||30.9.21|
||||||R||K||
|Unrestricted||funds|||||||
|General fund||||2,639,434|466,971|~437,528|52,328|2,721,207|
|Restricted|funds||||||||
|MRI fund||||42||||42|
|Heartbeat|House fund||||17,088|(11,788)||5,300|
|Heart Failure||Unit fund||46||||46|
|3D Printer|appeal||||2,319||(2,319)||
|Healthy
Living||Centre appeal|||50|||50|
|Paediatric|Palliative||Clinical Nurse appeal||1,973|||1,973|
|||||ee|21,430|~11,788|~2,319|7,411|
##
##